Illustris Pharmaceuticals Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $5M
Latest Deal Amount

Illustris Pharmaceuticals General Information

Description

Developer of molecule delivery technology designed to deliver ingredients that can permeate tissue structures. The company's technology provides a pathway through tissue structures that deliver active ingredients that deploy decoy, distract and relax anchors and binds tissue cells, enabling patients to optimize the absorption of compounds typically delivered through skin, eyes and mucous surfaces.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
  • 131 innovation drive
  • Suite 150
  • Irvine, CA 92617
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Illustris Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A2) 27-Feb-2017 $5M 00.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A1) 07-Nov-2016 00.00 00.00 0000 Completed Startup
To view Illustris Pharmaceuticals’s complete valuation and funding history, request access »

Illustris Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 000
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Illustris Pharmaceuticals’s complete cap table history, request access »

Illustris Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Janifer Yeo-Tan Co-Founder
You’re viewing 1 of 4 executive team members. Get the full list »

Illustris Pharmaceuticals Board Members (5)

Name Representing Role Since
Andrew Hirschberg Illustris Pharmaceuticals Board Member 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Illustris Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial